Two biotechs, SIGA and PharmAthene, vying to establish a foothold in the potentially vast biodefense market are in the midst of duking it out in a multibillion dollar legal battle. The crux of the dispute is a smallpox vaccine being developed for the military.
Continue reading Inside Wall Street: Two Biotechs Locked in Battle Over a Smallpox Vaccine
Inside Wall Street: Two Biotechs Locked in Battle Over a Smallpox Vaccine originally appeared on DailyFinance on Mon, 20 Dec 2010 07:30:00.
Filed Under: Company News, Columns, Investing, Health Care, American Eagle Outfitters